Business
Ketamine One Begins Trading on the OTCQB Marketplace on January 12, 2022
Ketamine One Begins Trading on the OTCQB Marketplace on January 12, 2022.
About this update from Wellbeing Digital Sciences Inc.
[{"type":"text","content":"\n VANCOUVER, British Columbia, Jan. 12, 2022 (GLOBE NEWSWIRE) -- KetamineOne Capital Limited (“Ketamine One” or the “Company”) (NEO: MEDI) (OTCQB: KONEF) (Frankfurt: MY0), a company focused on consolidating medical clinics and becoming a North American leader in mental health treatments, is pleased to announce that its common shares have been successfully up-listed (the “Up-Listing”) from the OTC Pink Sheet Open Market to the OTCQB Venture Market (the “OTCQB”) by the OTC Markets Group Inc. (“OTC Markets”). The Company’s common shares will begin trading on the OTCQB under the symbol \"KONEF\" as of the opening of the market on January 12, 2022. The Up-Listing complements the Company’s previous receipt of DTC Eligibility. Ketamine One’s common shares will continue to trade on the NEO Exchange under the symbol “MEDI” and the Frankfurt Stock Exchange under the symbol “MY0”. Operated by OTC Markets, the OTCQB offers transparent trading in entrepreneurial and development stage companies that have met a minimum bid price test, are current in their financial reporting and have undergone an annual verification and management certification process. The OTCQB is recognized by the United States (“US”) Securities and Exchange Commission as an established public market providing public information for analysis and value of securities. These standards provide a strong baseline of transparency, as well as the technology and regulations to improve the trading experience for investors. Ketamine One has a verified profile and is 12g3-2(b) Certified by OTC Markets. Investors or other interested parties in the US can obtain real-time quotes for Ketamine One as well as access its most current news and other information at www.otcmarkets.com. Shareholders will also now have greater access to information via the OTC Disclosure and News Service, as well as transparent prices through full depth-of-book with Real Time Level 2 quotes. “We are pleased for Ketamine One’s common shares to be accepted onto the OTCQB by OTC Markets. The listing of our shares on the OTCQB is important as it makes it easier for American investors to obtain information about our securities and purchase our stock. Combined with DTC Eligibility, the Up-Listi...